Progress in methods for evaluating Schwann cell myelination and axonal growth in peripheral nerve regeneration via scaffolds

Abstract

Peripheral nerve injury (PNI) is a neurological disorder caused by trauma that is frequently induced by accidents, war, and surgical complications, which is of global significance. The severity of the injury determines the potential for lifelong disability in patients. Artificial nerve scaffolds have been investigated as a powerful tool for promoting optimal regeneration of nerve defects. Over the past few decades, bionic scaffolds have been successfully developed to provide guidance and biological cues to facilitate Schwann cell myelination and orientated axonal growth. Numerous assessment techniques have been employed to investigate the therapeutic efficacy of nerve scaffolds in promoting the growth of Schwann cells and axons upon the bioactivities of distinct scaffolds, which have encouraged a greater understanding of the biological mechanisms involved in peripheral nerve development and regeneration. However, it is still difficult to compare the results from different labs due to the diversity of protocols and the availability of innovative technologies when evaluating the effectiveness of novel artificial scaffolds. Meanwhile, due to the complicated process of peripheral nerve regeneration, several evaluation methods are usually combined in studies on peripheral nerve repair. Herein, we have provided an overview of the evaluation methods used to study the outcomes of scaffold-based therapies for PNI in experimental animal models and especially focus on Schwann cell functions and axonal growth within the regenerated nerve.

Nicotinic Acetylcholine Receptors in Glial Cells as Molecular Target for Parkinson’s Disease

“…Remarkably, OPCs by themselves constitute a subclass (fourth subset) of glial cells that are described in detail below; (2) morphological differentiation, characterized by an elaborate network of processes; (3) the generation of compact myelin and the ensheathment around target axons; and (4) the metabolic and trophic support of the encased axon [ 117 ]. It is of relevance to note that in the peripheral nervous system, neuroglia that are equivalent to OLs are called Schwann cells [ 118 , 119 ].…”

Nicotinic Acetylcholine Receptors in Glial Cells as Molecular Target for Parkinson’s Disease

“…Remarkably, OPCs by themselves constitute a subclass (4th subset) of glial cells that are described in detail below; (2) morphological differentiation, characterized by an elaborate network of processes; (3) generation of compact myelin and ensheathment around target axons; and (4) metabolic and trophic support of the encased axon [117]. It is of relevance to note that in the peripheral nervous system, neuroglia that are equivalent to OLs are called Schwann cells [118,119].…”